Literature DB >> 32093856

Nintedanib Effect in Osimertinib-Induced Interstitial Pneumonia.

Wenfeng Fang1, Yihua Huang1, Jiadi Gan1, Bishan He2, Li Zhang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32093856     DOI： 10.1016/j.jtho.2019.09.086

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

Review 1.  The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.

Authors:  Giulia Maria Stella; Vito D'Agnano; Davide Piloni; Laura Saracino; Sara Lettieri; Francesca Mariani; Andrea Lancia; Chandra Bortolotto; Pietro Rinaldi; Francesco Falanga; Cristiano Primiceri; Angelo Guido Corsico; Andrea Bianco
Journal:  Transl Lung Cancer Res       Date:  2022-03

2.  Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.

Authors:  Xiao-Hong Xie; Hai-Yi Deng; Xin-Qing Lin; Jian-Hui Wu; Ming Liu; Zhan-Hong Xie; Yin-Yin Qin; Cheng-Zhi Zhou
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.